Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

PHF6 mutations in T-cell acute lymphoblastic leukemia

Abstract

Tumor suppressor genes on the X chromosome may skew the gender distribution of specific types of cancer1,2. T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with an increased incidence in males3. In this study, we report the identification of inactivating mutations and deletions in the X-linked plant homeodomain finger 6 (PHF6) gene in 16% of pediatric and 38% of adult primary T-ALL samples. Notably, PHF6 mutations are almost exclusively found in T-ALL samples from male subjects. Mutational loss of PHF6 is importantly associated with leukemias driven by aberrant expression of the homeobox transcription factor oncogenes TLX1 and TLX3. Overall, these results identify PHF6 as a new X-linked tumor suppressor in T-ALL and point to a strong genetic interaction between PHF6 loss and aberrant expression of TLX transcription factors in the pathogenesis of this disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Next-generation sequencing and microarray-based comparative genomic hybridization (array-CGH) analysis of the X chromosome identifies PHF6 mutations in human T-cell acute lymphoblastic leukemia (T-ALL).
Figure 2: PHF6 mutations and expression in T-cell acute lymphoblastic leukemia (T-ALL) lymphoblasts.
Figure 3: PHF6 expression in T-cell acute lymphoblastic leukemia (T-ALL) lymphoblasts.
Figure 4: Clinical and biological characteristics associated with PHF6 mutations in T-cell acute lymphoblastic leukemia (T-ALL).

Similar content being viewed by others

References

  1. Carrel, L., Cottle, A.A., Goglin, K.C. & Willard, H.F. A first-generation X-inactivation profile of the human X chromosome. Proc. Natl. Acad. Sci. USA 96, 14440–14444 (1999).

    Article  CAS  Google Scholar 

  2. Carrel, L. & Willard, H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400–404 (2005).

    Article  CAS  Google Scholar 

  3. Goldberg, J.M. et al. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J. Clin. Oncol. 21, 3616–3622 (2003).

    Article  Google Scholar 

  4. Aifantis, I., Raetz, E. & Buonamici, S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat. Rev. Immunol. 8, 380–390 (2008).

    Article  CAS  Google Scholar 

  5. Pui, C.H., Robison, L.L. & Look, A.T. Acute lymphoblastic leukaemia. Lancet 371, 1030–1043 (2008).

    Article  CAS  Google Scholar 

  6. Gnirke, A. et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 27, 182–189 (2009).

    Article  CAS  Google Scholar 

  7. Lower, K.M. et al. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat. Genet. 32, 661–665 (2002).

    Article  CAS  Google Scholar 

  8. Borjeson, M., Forssman, H. & Lehmann, O. An X-linked, recessively inherited syndrome characterized by grave mental deficiency, epilepsy, and endocrine disorder. Acta Med. Scand. 171, 13–21 (1962).

    Article  CAS  Google Scholar 

  9. Turner, G. et al. The clinical picture of the Borjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations. Clin. Genet. 65, 226–232 (2004).

    Article  CAS  Google Scholar 

  10. Baker, L.A., Allis, C.D. & Wang, G.G. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutat. Res. 647, 3–12 (2008).

    Article  CAS  Google Scholar 

  11. Dephoure, N. et al. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA 105, 10762–10767 (2008).

    Article  CAS  Google Scholar 

  12. Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160–1166 (2007).

    Article  CAS  Google Scholar 

  13. Lowndes, N.F. & Toh, G.W. DNA repair: the importance of phosphorylating histone H2AX. Curr. Biol. 15, R99–R102 (2005).

    Article  CAS  Google Scholar 

  14. Payer, B. & Lee, J.T. X chromosome dosage compensation: how mammals keep the balance. Annu. Rev. Genet. 42, 733–772 (2008).

    Article  CAS  Google Scholar 

  15. Carrel, L. & Willard, H.F. Heterogeneous gene expression from the inactive X chromosome: an X-linked gene that escapes X inactivation in some human cell lines but is inactivated in others. Proc. Natl. Acad. Sci. USA 96, 7364–7369 (1999).

    Article  CAS  Google Scholar 

  16. Ferrando, A.A. et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75–87 (2002).

    Article  CAS  Google Scholar 

  17. Soulier, J. et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 106, 274–286 (2005).

    Article  CAS  Google Scholar 

  18. Van Vlierberghe, P. et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111, 4668–4680 (2008).

    Article  CAS  Google Scholar 

  19. van Grotel, M. et al. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica 91, 1212–1221 (2006).

    Google Scholar 

  20. Marks, D.I. et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood 114, 5136–5145 (2009).

    Article  CAS  Google Scholar 

  21. Rumble, S.M. et al. SHRiMP: accurate mapping of short color-space reads. PLOS Comput. Biol. 5, e1000386 (2009).

    Article  Google Scholar 

  22. Khiabanian, H., Van Vlierberghe, P., Palomero, T., Ferrando, A.A. & Rabadan, R. ParMap, an algorithm for the identification of complex genomic variations in nextgen sequencing data. Nature Precedings published online, <http://hdl.handle.net/10101/npre.2010.4145.1> (12 January 2010).

  23. Clappier, E. et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 110, 1251–1261 (2007).

    Article  CAS  Google Scholar 

  24. Erdogan, F. et al. Impact of low copy repeats on the generation of balanced and unbalanced chromosomal aberrations in mental retardation. Cytogenet. Genome Res. 115, 247–253 (2006).

    Article  CAS  Google Scholar 

  25. Lahortiga, I. et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat. Genet. 39, 593–595 (2007).

    Article  CAS  Google Scholar 

  26. Voss, A.K. et al. Protein and gene expression analysis of Phf6, the gene mutated in the Borjeson-Forssman-Lehmann syndrome of intellectual disability and obesity. Gene Expr. Patterns 7, 858–871 (2007).

    Article  CAS  Google Scholar 

  27. González-García, S. et al. CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7Rα gene expression in early human thymopoiesis and leukemia. J. Exp. Med. 206, 779–791 (2009).

    Article  Google Scholar 

  28. Moffat, J. et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283–1298 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Fund for Scientific Research (FWO) Flanders (postdoctoral grants to P.V.V. and T.T., PhD grant to J.V.d.M., senior clinical investigator award to B.P. and project grants G.0198.08 and G.0869.10N to F.S.); the GOA-UGent (grant no. 12051203); the IWT-Vlaanderen (SBO grant no. 060848); the Children Cancer Fund Ghent (F.S.); Leukemia Research UK (C.J.H.); the Stichting Kinderen Kankervrij (KiKa; grant no. KiKa 2007-012 to L.Z.); the Belgian Program of Interuniversity Poles of Attraction; the Belgian Foundation against Cancer; the Austrian Ministry of Science and Research (GEN-AU Child, GZ 200.136/1-VI/1/2005 to S.S.), the US National Library of Medicine (1R01LM010140-01 to R.R. and H.K.); the ECOG and DCOG tumor banks; grants from Spain's Plan Nacional (BFU 2007-60990 and PlanE2009-0110 to M.L.T.), Comunidad de Madrid (S-SAL0304-2006 to M.L.T.), Fundación MM (M.L.T.), Instituto de Salud Carlos III (RECAVA RD06/0014/1012 to M.L.T.), an Institutional Grant from the Fundación Ramón Areces (M.L.T.), the Alex's Lemonade Stand Foundation Young Investigator Award (T.P.); a US Northeast Biodefense Center ARRA award (U54-AI057158 to R.R.); the US National Institutes of Health (R01CA120196 and R01CA129382 to A.F.); the Rally across America Foundation (A.F); the Swim across America Foundation (A.F.); the Golfers against Cancer Foundation (A.F.); and a Leukemia and Lymphoma Society Scholar Award (A.F.). We thank the Pediatric Cardiosurgery Units from Centro Especial Ramón y Cajal and Ciudad Sanitaria La Paz (Madrid, Spain) for thymus samples.

Author information

Authors and Affiliations

Authors

Contributions

P.V.V. performed array-CGH and mutation analysis of PHF6 and wrote the manuscript. T.P. performed exon capture and next-generation sequencing of T-ALL samples and wrote the manuscript. H.K. analyzed next-generation sequencing data. J.V.d.M. performed additional array-CGH analysis and PHF6 mutation screening in T-ALL and BCP-ALL samples. T.T., N.V.R. and A.W.L. performed experiments. M.C. and C.C.-C. performed and analyzed histological and immunohistochemical staining. J.P. collaborated on PHF6 mutation screening in BCP-ALL samples. C.J.H. and C.S. collaborated on additional screening for genomic PHF6 deletions in T-ALL. Y.B., B.D.M. and B.C. collaborated on the PHF6 mutation screening. R.P., M.P., S.S. and J.S. collaborated on the multicenter array-CGH study. S.G.-G. and M.L.T. performed the isolation of T-cell progenitor cells for expression analysis of PHF6. X.Y. performed survival analysis of ECOG T-ALL patients. J.G. provided critical reagents and discussion. E.S. provided samples and correlative clinical data from DCOG. E.P., J.M.R. and P.H.W. provided samples and correlative clinical data from ECOG. J.M. and L.Z. collaborated on the multicenter array-CGH study and PHF6 mutation analysis, provided molecular data on the characterization of T-ALL and performed survival analysis of PHF6 mutations in the DCOG series. R.R. designed and directed the analysis of next-generation sequencing results. F.S. and B.P. designed the studies and directed research. A.F. designed the studies, directed research and wrote the manuscript.

Corresponding author

Correspondence to Adolfo Ferrando.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1 and Supplementary Tables 1–7 (PDF 503 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Vlierberghe, P., Palomero, T., Khiabanian, H. et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet 42, 338–342 (2010). https://doi.org/10.1038/ng.542

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.542

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer